EVs derived from prostate and ovarian cancer express Fas ligand (FasL, also known as CD95L) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) (which induces T cell apoptosis), respectively; thus, they act as antigen-presenting death signals for CD8+ T cells.43 Here, FASLG is linked to ovarian carcinoma.